Millennium Management’s Exagen XGN Stock Holding History
Bought
Maintained
Sold
Other funds holding XGN
WC
VCM
NCNMGF
SAM
KCM
FCM
RI
MBAM
Millennium Management's XGN Position: Q1 2026 in Review
Millennium Management reduced its Exagen (XGN) stake by 75% in Q1 2026, selling an estimated $652K and leaving 56,069 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #5229.
Millennium Management first reported a position in XGN in Q3 2019 and has held it in 18 quarters since. The position peaked at $2.72M in Q3 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.
- Millennium Management held 56,069 shares of Exagen worth $168K as of Q1 2026.
- Millennium Management sold 168,540 Exagen shares in Q1 2026, an estimated $652K.
- Exagen made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5229 holding.
- Millennium Management first reported a position in Exagen in Q3 2019 and has held it in 18 quarters since.
- Millennium Management's Exagen position peaked at $2.72M in Q3 2025.
- 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.